It was determined that HSP90B1 binds to epidermal growth factor receptor (EGFR) and promotes NPC development by activating the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway. This evidence concerns the gene HSP90B1 and nasopharyngeal carcinoma.